Literature DB >> 1499305

Everyday memory after unilateral temporal lobectomy or amygdalo-hippocampectomy.

L H Goldstein1, C E Polkey.   

Abstract

Patients who had undergone unilateral temporal lobe surgery (right or left temporal lobectomy or amygdalo-hippocampectomy) for intractable temporal lobe epilepsy, and normal control subjects, completed two questionnaires about everyday memory, the Subjective Memory Questionnaire (SMQ) and the Everyday Memory Questionnaire (EMQ). Relatives/close friends completed suitably adapted versions of these questionnaires about the patient. Patients who had undergone right and left temporal lobectomy rated themselves, and were rated by relatives/friends as having worse memories than controls on both the SMQ and EMQ. Individual items on both questionnaires differentiated between the memory abilities of the five groups. Age at surgery was correlated with one measure of everyday memory for the right temporal lobectomy group, and seizure frequency was correlated with memory performance for the amygdalo-hippocampectomy groups. Issues concerning validity and accuracy of rating memory lapses are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1499305     DOI: 10.1016/s0010-9452(13)80047-0

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  2 in total

1.  Association of perceived health and depression with older adults' subjective memory complaints: contrasting a specific questionnaire with general complaints questions.

Authors:  Pedro Montejo; Mercedes Montenegro; Miguel A Fernández-Blázquez; Agustín Turrero-Nogués; Raquel Yubero; Evelio Huertas; Fernando Maestú
Journal:  Eur J Ageing       Date:  2013-07-31

2.  Neuropsychological effects associated with temporal lobectomy and amygdalohippocampectomy depending on Wada test failure.

Authors:  M E Lacruz; G Alarcón; N Akanuma; F C K Lum; N Kissani; M Koutroumanidis; N Adachi; C D Binnie; C E Polkey; R G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.